Leading the fight against cancer. Always focused on you.
We deliver personalized treatment you won't get anywhere else, led by a team of world-renowned doctors, specialists, and scientists.
Give today. Impact the care of tomorrow.
Your generosity helps support groundbreaking research, world-class care for patients and their families, and vital education programs to train the next generation of cancer experts.
Changing how the world treats cancer through research
Our scientists pursue every aspect of cancer research — from exploring the fundamental biology of genes and cells, to developing immune-based treatments for cancer, uncovering the causes of metastasis, and more.
Find your life's calling
We're here for a reason: Every day, we're working toward a better future. Whether you're experienced or just starting your career, there's a place for you at MSK.
Let's get started
Many treatments and services are available at locations across NY and NJ.
Get care from the comfort of your home with telemedicine from MSK.
Explore MSK’s clinical trials
Our doctors and scientists work together so patients get access to cutting-edge treatments as soon as they are available.
Cancer news & discoveries
Article
FDA Approves First Targeted Drug to Treat HER2 Low Breast Cancer: Trastuzumab Deruxtecan (T-DXd)
On August 5, 2022, the FDA approved the first targeted therapy for patients with HER2-low breast cancer that has spread to other parts of the body and is unable to be surgically removed. The drug trastuzumab deruxtecan (T-DXd) was approved based on a clinical trial led by Memorial Sloan Kettering Cancer Center (MSK) breast medical oncologist Shanu Modi.
Read more
Article
Annual Report: Bold Discovery. Life-Changing Care.
Our three pillars — patient care, scientific research, and education — supported extraordinary progress last year. Read more about our most promising developments in 2021.
Read more
Podcast | Cancer Straight Talk
Finding Hope and Acceptance in a Cancer Diagnosis: One Couple’s Advice
You’ve received a cancer diagnosis. Now what? For George Kolasa, it was obvious: use his glioblastoma diagnosis for good. “I’ve been chosen,” he says.
Listen to the podcast